Cargando…
Adenovirus Biology, Recombinant Adenovirus, and Adenovirus Usage in Gene Therapy
Gene therapy is currently in the public spotlight. Several gene therapy products, including oncolytic virus (OV), which predominantly replicates in and kills cancer cells, and COVID-19 vaccines have recently been commercialized. Recombinant adenoviruses, including replication-defective adenoviral ve...
Autores principales: | Watanabe, Maki, Nishikawaji, Yuya, Kawakami, Hirotaka, Kosai, Ken-ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706629/ https://www.ncbi.nlm.nih.gov/pubmed/34960772 http://dx.doi.org/10.3390/v13122502 |
Ejemplares similares
-
Cytokine Responses to Adenovirus and Adenovirus Vectors
por: Atasheva, Svetlana, et al.
Publicado: (2022) -
Complement activation by recombinant adenoviruses
por: Cichon, G, et al.
Publicado: (2002) -
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
por: Hensen, Lobke C.M., et al.
Publicado: (2020) -
No more helper adenovirus: production of gutless adenovirus (GLAd) free of adenovirus and replication-competent adenovirus (RCA) contaminants
por: Lee, Dongwoo, et al.
Publicado: (2019) -
Oncolytic Adenoviruses for Cancer Therapy
por: Tripodi, Lorella, et al.
Publicado: (2021)